Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Desmoid Tumors × Imatinib Mesylate × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 55 Leukemia 31 Gastrointestinal Stromal Tumors 26 Leukemia, Myeloid, Chronic-Phase 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Philadelphia Chromosome 8 Neoplasm Metastasis 8 Melanoma 8 Lung Neoplasms 8 Blast Crisis 8 Brain Neoplasms 7 Neoplasms 5 Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Small Cell Lung Carcinoma 4 Recurrence 4 Prostatic Neoplasms 4 Primary Myelofibrosis 4 Polycythemia Vera 4 Ovarian Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Myeloid, Acute 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Myeloid 4 Dermatofibrosarcoma 4 Sarcoma 3 Osteosarcoma 3 Meningioma 3 Head and Neck Neoplasms 3 Gliosarcoma 3

Interventions

nirogacestat 4 Toremifene 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 X-Rays 1 Vinblastine 1 Taxes 1 Tamoxifen 1 Sunitinib 1 Sulindac 1 Radiotherapy 1 Phantoms, Imaging 1 Nivolumab 1 Methotrexate 1 Ipilimumab 1 Imatinib Mesylate 1 Hydroxyurea 1 Cryosurgery 1 CTLA-4 Antigen 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01137916 2017-05-03

Study to Evaluate Imatinib in Desmoid Tumors

Heidelberg University

Phase 2 Completed

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡